Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.37 |
| ▸ | SMO | Q99835 | 5/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21623401 | 1.00 | CNR2 (0.40) | CNR2KMT2APARP10TSHRMAPK14 | |
| SCHEMBL21617236 | 0.86 | KMT2A (0.38) | CNR2KMT2ATSHRMAPK14SMO | |
| SCHEMBL31504454 | 0.86 | KMT2A (0.38) | CNR2KMT2ATSHRMAPK14SMO | |
| SCHEMBL23308003 | 0.81 | CNR2 (0.39) | CNR2KMT2AMAPK14SMOTYK2 | |
| SCHEMBL21623470 | 0.77 | CNR2 (0.40) | CNR2KMT2AMAPK14SMOTYK2 | |
| SCHEMBL31504445 | 0.77 | CNR2 (0.40) | CNR2KMT2AMAPK14SMOTYK2 | |
| SCHEMBL21617298 | 0.75 | PARP10 (0.52) | CNR2PARP10MAPK14SMOTYK2 | |
| SCHEMBL31504428 | 0.75 | PARP10 (0.52) | CNR2PARP10MAPK14SMOTYK2 | |
| SCHEMBL21617171 | 0.74 | CNR2 (0.39) | CNR2KMT2AMAPK14SMO | |
| SCHEMBL31504377 | 0.74 | CNR2 (0.39) | CNR2KMT2AMAPK14SMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638877-B | Phenyl/pyridinyl-N-phenyl/pyridinyl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2025-04-22 | — | — | CN | disclosed |